Big Move For CNS Pharmaceuticals, Inc.
Wed, Aug 20, 2025 at 07:52 PM
CNS Pharmaceuticals, Inc. (CNSP:NASDAQ) jumped higher at $6.97, representing a gain of 28.8%. On Wed, Aug 20, 2025, CNSP:NASDAQ touched a New 2-Week Intraday High of $7.31. The stock got featured on our News Catalysts scanner on Fri, Aug 15, 2025 at 11:15 AM in the 'INVESTOR UPDATE' category. From Wed, Aug 06, 2025, the stock recorded 30.00% Up Days and 27.27% Green Days
About CNS Pharmaceuticals, Inc. (CNSP:NASDAQ)
CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma.
Top 10 Gainers:
- Hempacco Co., Inc. (HPCO:NASDAQ), 350%
- Tharimmune, Inc. (THAR:NASDAQ), 206.81%
- Smart for Life, Inc. (SMFL:NASDAQ), 92.31%
- NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT), 71.67%
- Alpha Technology Group Limited (ATGL:NASDAQ), 51.49%
- Shineco, Inc. (SISI:NASDAQ), 36.97%
- Pop Culture Group Co., Ltd (CPOP:NASDAQ), 36.14%
- Radiopharm Theranostics Limited (RADX:NASDAQ), 32.87%
- Rocket Pharmaceuticals, Inc. (RCKT:NASDAQ), 28.87%
- CNS Pharmaceuticals, Inc. (CNSP:NASDAQ), 28.84%